Technology appraisal guidance [TA333] Published: 25 February 2015
6.1 The guidance on this technology will be considered for review at the same time as NICE technology appraisal guidanceĀ 178 and 219 for the secondāline treatment of advanced renal cell carcinoma. Andrew DillonChief ExecutiveFebruary 2015